Karyopharm Therapeutics Inc.
USD7.87
+0.40 (+5.29%)
CEO
Richard A. Paulson
IPO Date
2013-11-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$7.59
Prev. Close
$7.47
Day Low
$7.46
Day High
$8.27
52W Low
$3.65
52W High
$10.99
Market Cap
$0.18B
Volume
0.94M
| 15,508 |
| $0.00 |
| 26 May 2026 | Schor Chen | director | A-Award | Acquired | 15,508 | $0.00 |
| 26 May 2026 | Su Zhen | director | A-Award | Acquired | 15,508 | $0.00 |
| 26 May 2026 | BOHLIN GAREN G | director | A-Award | Acquired | 15,508 | $0.00 |
| 26 May 2026 | Greene Barry E | director | A-Award | Acquired | 15,508 | $0.00 |
| 15 May 2026 | Poulton Stuart | EVP, Chief Development Officer | A-Award | Acquired | 896 | $0.00 |
| 15 May 2026 | Poulton Stuart | EVP, Chief Development Officer | S-Sale | Disposed | 403 | $9.50 |
| 15 May 2026 | Rangwala Reshma | EVP & Chief Medical Officer | A-Award | Acquired | 947 | $0.00 |
| 15 May 2026 | Rangwala Reshma | EVP & Chief Medical Officer | S-Sale | Disposed | 408 | $9.50 |